Clinical trials - Press Releases

Date	Title	Company
16-Apr-2021	PharmiWeb.Jobs Welcomes Medical Developments International	Medical Developments International
16-Apr-2021	New data for Roche’s OCREVUS (ocrelizumab) reinforce significant benefit on slowing disease progression in relapsing and primary progressive multiple sclerosis	Roche
16-Apr-2021	Roche’s Evrysdi continues to improve motor function and survival in babies with Type 1 Spinal Muscular Atrophy (SMA)	Roche
16-Apr-2021	Merck and Ridgeback Biotherapeutics Provide Update on Progress of Clinical Development Program for Molnupiravir, an Investigational Oral Therapeutic for the Treatment of Mild-to-Moderate COVID-19	Merck
15-Apr-2021	Top 10 Reasons to join SMi's 4th Annual Pharmaceutical Microbiology West Coast Virtual Conference	SMi Group
15-Apr-2021	Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations	Novavax
14-Apr-2021	Hope for poorer nations as a food staple, sodium-bicarbonate was found in a peer-reviewed study to significantly reduce Covid symptoms	Copper Clothing
14-Apr-2021	Tagrisso is the only targeted medicine to show efficacy in the treatment of early-stage lung cancer in a global trial and the first such medicine approved in China	AstraZeneca
14-Apr-2021	Boehringer Ingelheim and Zealand Pharma Advance to Phase 2 Clinical Testing in NASH and Obesity	Boehringer Ingelheim
13-Apr-2021	First patient dosed in phase 3 XTEND-Kids study with efanesoctocog alfa in children with haemophilia A	Swedish Orphan Biovitrum AB (publ) (Sobi™)
13-Apr-2021	iTeos Therapeutics Announces New Preliminary Data Indicating Clinical Activity with its Anti-TIGIT Antibody, EOS-448, at the AACR Annual Meeting 2021	iTeos Therapeutics
13-Apr-2021	Lundbeck and Otsuka announce decision to continue phase III clinical trial evaluating brexpiprazole for treatment of agitation in patients with Alzheimer’s-type dementia	Lundbeck and Otsuka
13-Apr-2021	CloudLIMS Adds a HIPAA-Compliant Patient Portal to its COVID-19 LIMS for Diagnostic Labs to Offer a Seamless Experience to Testees	CloudLIMS
13-Apr-2021	Myovant Sciences and Pfizer Announce First Participant Dosed in Phase 3 Serene Study Evaluating Contraceptive Efficacy of Once-Daily Relugolix Combination Tablet	Pfizer
12-Apr-2021	Update on the DARE-19 Phase III trial for Farxiga in COVID-19	AstraZeneca
12-Apr-2021	Lilly Presents New Data on Retevmo® (selpercatinib) in Advanced RET Fusion-Positive Gastrointestinal and Other Cancers at 2021 American Association for Cancer Research (AACR) Annual Meeting	Lilly
12-Apr-2021	Phase III prevention trial showed subcutaneous administration of investigational antibody cocktail casirivimab and imdevimab reduced risk of symptomatic COVID-19 infections by 81%	Roche
09-Apr-2021	Occupational Toxicology and Placing Worker Safety at the Forefront to be discussed at HPAPi Conference	SMi Group
09-Apr-2021	Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients	Lilly
09-Apr-2021	Interim late-breaking clinical data validate not-alpha profile of THOR-707 (SAR444245), Sanofi’s novel investigational IL-2	Sanofi